Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3,835,126 | $3,680,546 | $7,096,510 | $7,720,598 |
| - Cash | $675,000 | $693,000 | $706,000 | $737,000 |
| + Debt | $8,880,000 | $8,931,000 | $9,112,000 | $9,364,000 |
| Enterprise Value | $12,040,126 | $11,918,546 | $15,502,510 | $16,347,598 |
| Revenue | $6,403,000 | $6,263,000 | $6,174,000 | $6,304,000 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Gross Profit | $3,715,000 | $3,748,000 | $3,880,000 | $3,922,000 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| EBITDA | $1,604,000 | $1,436,000 | $1,756,000 | $1,982,000 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |
| Net Income | $864,000 | $1,023,000 | $917,000 | $1,351,000 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| % Growth | -16.5% | 11.1% | -32.6% | – |
| Operating Cash Flow | $939,000 | $799,000 | $858,000 | $2,458,000 |
| Capital Expenditures | -$351,000 | -$261,000 | -$427,000 | -$488,000 |
| Free Cash Flow | $588,000 | $538,000 | $431,000 | $1,970,000 |